Skip to content

A clinical study to compare the effects of Gokshuradi tablets and Cystone tablets in reducing urinary calculi size of selected Urolithiasis participants in the age group of 20 to 65 years: A Randomized Controlled Trial

Efficacy of Gokshuradi tablet in Urolithiasis: A Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/081307
Enrollment
48
Registered
2025-02-25
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N209- Urinary calculus, unspecified

Interventions

None listed

Sponsors

Dr Aswathy G
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Participants aged between 20-65 years diagnosed as Urolithiasis of irrespective of gender. 2.Calculi size in between 2mm-10mm by ultrasonography abdomen. 3.Participants who are willing to participate in the study.

Exclusion criteria

Exclusion criteria: 1.Participants with Chronic kidney disease, hydronephrosis(Grade 3 & 4), Gout, other Kidney disorders. 2.Known case of malignacy. 3.Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
1. Size of calculi in USG (2mm-10mm)Timepoint: Baseline and 91st day

Secondary

MeasureTime frame
1. Urine investigations - deposits,pus cells,RBC in urine 2.Blood test- Renal function test(Serum uria and serum creatine). 3.Changes in symptom assessment scoring include pain,burning micturition,dysuria,tenderness in renal angle.Timepoint: Baseline,31st,61st and 91st days

Countries

India

Contacts

Public ContactDr M S Deepa

Government Ayurveda College Thiruvananthapuram

shahulanchal@gmail.com9495311820

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026